Bristol-Myers Squibb Company, Ltd.
GPTKB entity
Properties (40)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
gptkb:Celgene_Corporation
gptkb:Immunomedics gptkb:Myokardia |
| gptkbp:CEO |
Giovanni Caforio
|
| gptkbp:employees |
30,000+
|
| gptkbp:founded |
1887
|
| gptkbp:founder |
gptkb:William_McLaren_Bristol
gptkb:John_Ripley_Myers |
| gptkbp:headquarters |
gptkb:New_York
gptkb:New_York_City gptkb:United_States |
| https://www.w3.org/2000/01/rdf-schema#label |
Bristol-Myers Squibb Company, Ltd.
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:notableFeature |
gptkb:Zeposia
gptkb:Opdivo gptkb:Orencia Nexavar Reblozyl Eliquis Yervoy |
| gptkbp:partnerships |
gptkb:AstraZeneca
gptkb:NantKwest gptkb:Boehringer_Ingelheim gptkb:Pfizer gptkb:Regeneron_Pharmaceuticals gptkb:Eli_Lilly_and_Company AbbVie |
| gptkbp:products |
drugs
|
| gptkbp:researchFocus |
oncology
fibrosis immunology cardiovascular |
| gptkbp:revenue |
$46.4 billion (2020)
|
| gptkbp:stockSymbol |
BMY
|
| gptkbp:subsidiary |
gptkb:Immunomedics
gptkb:Myokardia Celgene |
| gptkbp:tradedOn |
gptkb:New_York_Stock_Exchange
|
| gptkbp:website |
www.bms.com
|